Literature DB >> 22771030

Does the level of serum antimüllerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging?

Enrico Carmina1, Anna Maria Campagna, Pasquale Mansuet, Giustina Vitale, Daniel Kort, Roger Lobo.   

Abstract

OBJECTIVE: To determine possible prediction of regular menses with aging in anovulatory women with polycystic ovary syndrome (PCOS).
DESIGN: Cohort.
SETTING: Academic practice. PATIENT(S): A total of 54 anovulatory women with PCOS and 28 age- and weight-matched control subjects. INTERVENTION(S): Blood and ovarian ultrasound at baseline and after 5 years. MAJOR OUTCOME MEASURE(S): Serum antimüllerian hormone (AMH), gonadotropins, androgens, insulin sensitivity, and ovarian ultrasound. RESULT(S): After 5 years, there was a significant decrease in AMH in women with PCOS and control subjects (10 of 54 anovulatory women became ovulatory after 5 years). There was a significant negative correlation between baseline serum AMH and ovulatory function after 5 years. However, baseline serum AMH ≤ 4 ng/mL was associated with ovulatory function. CONCLUSION(S): Serum AMH may help predict ovulatory function with aging in anovulatory women with PCOS.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771030     DOI: 10.1016/j.fertnstert.2012.06.017

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program.

Authors:  Catherine Kim; Vanita R Aroda; Ronald B Goldberg; Naji Younes; Sharon L Edelstein; MaryLou Carrion-Petersen; David A Ehrmann
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

Review 2.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

3.  Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

Authors:  Corrine K Welt; Enrico Carmina
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

4.  Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index.

Authors:  Julie S Rios; Eleni A Greenwood; Mary Ellen G Pavone; Marcelle I Cedars; Richard S Legro; Michael P Diamond; Nanette Santoro; Fangbai Sun; Randal D Robinson; Gregory Christman; Heping Zhang; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

5.  Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis.

Authors:  Shahrzad Zadehmodarres; Zahra Heidar; Zahra Razzaghi; Leili Ebrahimi; Kaveh Soltanzadeh; Farhang Abed
Journal:  Iran J Reprod Med       Date:  2015-04

6.  Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.

Authors:  Do Kyeong Song; Jee-Young Oh; Hyejin Lee; Yeon-Ah Sung
Journal:  Korean J Intern Med       Date:  2016-11-30       Impact factor: 2.884

7.  Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies.

Authors:  Sylvia Kiconco; Chau Thien Tay; Kate Louise Rassie; Ricardo Azziz; Helena J Teede; Anju E Joham
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

8.  An overview of polycystic ovary syndrome in aging women

Authors:  Özlem Çelik; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2021-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.